Atrium Therapeutics, Inc. (RNA) stock
RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.64+0.16 (+2.47%)
Close on Nov 18, 2026Market cap $113.58MP/E –Yield –
Atrium Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Atrium Therapeutics's market cap was $136.16M on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $136.16M | – |
See a number that looks wrong?